Patent Number | Patent Title | Company | Revoked Date | Oppositions |
---|---|---|---|---|
EP1997473B1 | Use Of A Multi-Carbosite, Multi-Group Coupling Agent For Protecting The Colour Of Artificially Dyed Keratin Fibres With Respect To Washing; Dyeing Processes | LOREAL SA |
Dec, 2020
|
HENKEL
|
EP2044947B1 | Compositions And Methods | OXFORD UNIVERSITY INNOVATION LTD |
Dec, 2020
|
IMUTEX
|
EP2349332B1 | Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6 | GENERAL HOSPITAL CORP |
Dec, 2020
|
MATHYS & SQUIRE
|
EP2355902B1 | Nutritional Compositions With Coated Lipid Globules | NUTRICIA NV |
Dec, 2020
|
ABBOTT LABORATORIES
CARGILL
|
EP1441702B1 | Method For Treating Primary Insomnia | NEURIM PHARMACEUTICALS 1991 LTD |
Dec, 2020
|
ASPIRE PHARMA
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
|
EP2734185B1 | Dyeing Process Using A Natural Dye On Keratin Fibres That Have Undergone Permanent Reshaping | LOREAL SA |
Dec, 2020
|
KAO GERMANY
|
EP3060195B1 | Cosmetic Composition Based On Hyaluronic Acid, Method Of Preparation And Use Thereof | CONTIPRO AS |
Dec, 2020
|
STELLENBOSCH NANOFIBER
|
EP2198833B1 | Method Of Coloring Or Lightening Of Human Keratinic Fibers With An Anhydrous Composition And An Inorganic Base And Kit | LOREAL SA |
Dec, 2020
|
HENKEL
|
EP2787965B1 | Composition Based On Red Henna Powder And Oil(S), And Hair Dyeing Process Using This Composition | LOREAL SA |
Dec, 2020
|
COTY
HENKEL
|
EP2792715B1 | Semi-Synthetic Or Synthetic Vaselines | AIGLON |
Dec, 2020
|
SASOL WAX
|
EP2187965B1 | Psma Binding Ligand-Linker Conjugates And Methods For Using | PURDUE RESEARCH FOUNDATION |
Dec, 2020
|
BOULT WADE TENNANT
ORANO MED
|
EP1294379B1 | A New Use For Deferiprone | APOTEX INC |
Dec, 2020
|
LIPOMED
|
EP2214642B1 | Topical Composition | NOVARTIS CONSUMER HEALTH SA |
Dec, 2020
|
KERN PHARMA
PRFER & PARTNER MBB
|
EP2345400B1 | Lightening Composition Having Reduced Hair Damage | HENKEL AG AND CO KGAA |
Dec, 2020
|
KAO GERMANY
|
EP3050556B1 | Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate | TEVA PHARMACEUTICAL INDUSTRIES LTD |
Nov, 2020
|
GENERICS UK TRADING MYLAN
WITTKOPP
|
EP3031920B1 | Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression | IONIS PHARMACEUTICALS INC |
Nov, 2020
|
STRAWMAN
|
EP2687213B1 | Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, And Uses Thereof | CELGENE CORP |
Nov, 2020
|
GENERICS UK
|
EP3340990B1 | Pharmaceutical Combinations Comprising (A) The Cyclin Dependent Kinase 4/6 (Cdk4/6) Inhibitor Lee011 (=Ribociclib), And (B) The Epidermal Growth Factor Receptor (Egfr) Inhibitor Erlotinib, For The Treatment Or Prevention Of Cancer | NOVARTIS AG |
Nov, 2020
|
GENERICS UK
|
EP3456374B1 | Implant Syringe | GAPLAST GMBH |
Nov, 2020
|
AMW
|
EP3068396B1 | Rapidly Disintegrating Formulations And Methods Of Use | IMPAX LABORATORIES LLC |
Oct, 2020
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
|
EP2288717B1 | Monoclonal Antibodies To Basic Fibroblast Growth Factor | GALAXY BIOTECH LLC |
Oct, 2020
|
STRAWMAN
|
EP3312196B1 | Antibodies Against Cd38 For Treatment Of Multiple Myeloma | GENMAB AS |
Oct, 2020
|
SECERNA
|
EP2200588B1 | Compositions Comprising Lipophilic Active Compounds And Method For Their Preparation | SOLUBEST LTD |
Oct, 2020
|
DSM NUTRITIONAL PRODUCTS
|
EP2477638B1 | Probiotic Stabilization | MJN US HOLDINGS LLC |
Oct, 2020
|
CHR HANSEN NATURAL COLORS
NUTRICIA
|
EP2762140B1 | Treatment Of Solid Brain Tumours With A Rapamycin Derivative | NOVARTIS AG |
Oct, 2020
|
ETHYPHARM
GENERICS UK
|
EP2359800B1 | Composition For Cosmetic Treatment Of Keratin Fibres Comprising Volatile Linear Alkanes, C8-30 Fatty Alcohols And Mono- Or Polyglycosides | LOREAL SA |
Oct, 2020
|
HENKEL
|
EP3092226B1 | Indazole Compounds As Irak4 Inhibitors | AURIGENE DISCOVERY TECHNOLOGIES LTD |
Oct, 2020
|
BAYER BAYER PHARMA
|
EP2776066B1 | Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging | UNIVERSITE LAVAL |
Oct, 2020
|
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
|
EP1617820B1 | Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency | VECTURA LTD |
Oct, 2020
|
TEVA UK
|
EP2766014B1 | Methods Of Treating Pediatric Patients Using Dexmedetomidine | HOSPIRA INC |
Sep, 2020
|
FRESENIUS KABI DEUTSCHLAND
|
EP2164496B1 | Formulations Containing Triazinones And Iron | BAYER INTELLECTUAL PROPERTY GMBH |
Sep, 2020
|
CEVA SANTE ANIMALE
|
EP2753191B1 | Use Of Infant Formula With Large Lipid Globules | NUTRICIA NV |
Sep, 2020
|
NESTEC
|
EP2949335B1 | Low Frequency Glatiramer Acetate Therapy | YEDA RESEARCH AND DEVELOPMENT CO LTD |
Sep, 2020
|
ALVOGEN IPCO
GENERICS UK TRADING MYLAN
G L PHARMA
HEXAL
MYLAN TEORANTA TRADING MYLAN INSTITUTIONAL
SYNTHON BVGENTHON
|
EP2968302B9 | Combination Of Direct Acting Antiviral Agents And Ribavirin For Treating Hcv Patients | ABBVIE INC |
Sep, 2020
|
GENERICS UK
|
EP2073828B1 | Composition To Treat Or Prevent Gastrointestinal Infection | NUTRICIA NV |
Aug, 2020
|
FRESENIUS KABI DEUTSCHLAND
|
EP2797576B1 | Hair Dyeing Composition | KAO GERMANY GMBH |
Aug, 2020
|
HENKEL
|
EP2678011B1 | Antitumoral Combination Comprising Cabazitaxel And Cisplatin | AVENTIS PHARMA SA |
Aug, 2020
|
GENERICS UK
|
EP3116534B1 | Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders | BAXALTA GMBH |
Aug, 2020
|
OCTAPHARMA
|
EP1579847B1 | Cosmetic And Dermatological Solar Compositions | BEIERSDORF AG |
Jul, 2020
|
BASF
DALLI WERKE
EMIL KIESSLING
MERCK PATENT
STADA ARZNEIMITTEL
|
EP2624859B1 | Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders | MEDIMMUNE LTD |
Jul, 2020
|
STRAWMAN
|
EP2922532B1 | 5-Aminosalicylic Acid Capsule Formulation | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
Jul, 2020
|
WIBBELMANN
|
EP3186281B1 | Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor | HALOZYME INC |
Jul, 2020
|
J A KEMP
|
EP2509565B1 | Emulsifier-Free, Polymer-Stabilized Foam Formulations | NEUBOURG SKIN CARE GMBH AND CO KG |
Jul, 2020
|
HENKEL
|
EP1477189B1 | Process For Production Of Pressure-Sensitive Adhesive Moldings Comprising Crosslinked Polymers As The Main Component | HISAMITSU PHARMACEUTICAL CO INC |
Jun, 2020
|
LTS LOHMANN THERAPIE SYSTEME
|
EP3250185B1 | Ophthalmic Suspension Composition | BAUSCH AND LOMB INC |
Jun, 2020
|
ALLERGAN
BREUER
EUROPEAN OPPOSITIONS
|
EP3038647B1 | Combination Therapy For The Treatment Of Glioblastoma | F HOFFMANN LA ROCHE AG |
Jun, 2020
|
AMGEN
NEUEFEIND
|
EP2818156B1 | Perfumed Cosmetic Preparation | BEIERSDORF AG |
Jun, 2020
|
BASF
DALLI WERKE
|
EP2954892B1 | Solid Compositions | ABBVIE IRELAND ULC |
Jun, 2020
|
AECHTER
|
EP1714960B1 | Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als | MITSUBISHI TANABE PHARMA CORP |
May, 2020
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
|
EP1768646B1 | Cosmetic Sprays | UNILEVER PLC |
May, 2020
|
HENKEL
|
EP3086761B1 | Aqueous Cosmetic Composition Comprising Alkylcellulose, Non-Volatile Oils, A Hydrophilic Gelling Polymer And A Polyol | LOREAL SA |
Apr, 2020
|
HENKEL
|
EP2944323B1 | Agents For Treating Tumours, Use And Method Thereof | DINGFU BIOTARGET CO LTD |
Apr, 2020
|
GLAXOSMITHKLINE
MERCK PATENT
PFIZER
|
EP1633766B1 | Modified Fluorinated Nucleoside Analogues | GILEAD PHARMASSET LLC |
Apr, 2020
|
GILLARD
|
EP2258346B1 | Solid Pharmaceutical Dosage Form Comprising An Hiv Protease Inhibitor Solid Dispersion | ABBVIE INC |
Apr, 2020
|
F HOFFMANN LA ROCHE
|
EP2213284B1 | Preparation For Application To Body Surface And Preparation Holding Sheet For Application To Body Surface | BIOSERENTACH CO LTD |
Apr, 2020
|
LEO PHARMA
LTS LOHMANN THERAPIE SYSTEM
|
EP2988722B1 | Composition Comprising Henna And/Or Indigo, An Oil And A Saccharide, And Hair Dyeing Process Using The Same | LOREAL SA |
Apr, 2020
|
COTY
|
EP2582697B1 | Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them | NANOFORM CARDIOVASCULAR THERAPEUTICS LTD |
Mar, 2020
|
ALKERMES PHARMA IRELAND
|
EP3045176B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
Mar, 2020
|
GENERICS UK
|
EP3045175B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
Mar, 2020
|
GENERICS UK
|
EP1962778B1 | Improved Oral Compositions Comprising Zinc Citrate And/Or Tocopherol Agents | COLGATE PALMOLIVE CO |
Mar, 2020
|
UNILEVER UNILEVER
|
EP2598121B1 | A Method Of Controlling The Release Of An Active Ingredient From A Dosage Form | DOW GLOBAL TECHNOLOGIES LLC |
Mar, 2020
|
TYLOSE & COKG
|
EP3042659B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
Mar, 2020
|
BACHELIN
GENERICS UK
HAMM&WITTKOPP PATENTANWLTE PARTMBB
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
PRU
|
EP3025705B8 | Stable Ivabradine Formulations | SANOFI ILAC SANAYI VE TICARET AS |
Mar, 2020
|
HGF
|
EP3119436B1 | Sheet-Like Structure For The Controlled Release Of Active Substances | CARL FREUDENBERG KG |
Mar, 2020
|
MAHLE
|
EP3204045B1 | Pharmaceutical Formulations For The Oral Delivery Of Peptide Or Protein Drugs | CYPRUMED GMBH |
Mar, 2020
|
SANOFI
|
EP2731613B1 | Treatment Of Excessive Menstrual Bleeding Associated With Uterine Fibroids | PREGLEM SA |
Mar, 2020
|
ACCORD HEALTHCARE
GENERICS UK
HELM
HEXAL
ZENTIVA KS
|
EP2403520B1 | Insulin Formulations For Rapid Uptake | ELI LILLY AND CO |
Mar, 2020
|
BOHMANN
MAIKOWSKI & NINNEMANN PATENTANWLTE PARTNERSCHAFT MBB
|
EP2582683B1 | Treatment Of Gout And Hyperuricemia | ARDEA BIOCIENCES INC |
Mar, 2020
|
ALFRED E TIEFENBACHER
BLLE DR
HEXAL
|
EP2547216B1 | Infant Nutrition For Improving Fatty Acid Composition Of Brain Membranes | NUTRICIA NV |
Feb, 2020
|
ABBOTT LABORATORIES
|
EP2535355B1 | Antibodies Against Cd38 For Treatment Of Multiple Myeloma | GENMAB AS |
Feb, 2020
|
SECERNA
|
EP3076930B1 | Agent For Oxidatively Dyeing Hair Containing Specific Combinations Of Developers And Couplers | HENKEL AG AND CO KGAA |
Feb, 2020
|
LOREAL
|
EP2421841B1 | Improved Method Of Achieving And Maintaining A Specified Alkylene Oxide Production Parameter With A High Efficiency Catalyst | DOW TECHNOLOGY INVESTMENTS LLC |
Feb, 2020
|
BASF
|
EP2550972B1 | Klotho-Beta For Use In Treating Cancer, Liver Disorders, Gallstones, Wasting Syndrome And Obesity-Related Diseases | GENENTECH INC |
Feb, 2020
|
MATHYS & SQUIRE
NGM BIOPHARMACEUTICALS
|
EP2477617B1 | Free-Standing Biodegradable Patch | BIOINSPIRE TECHNOLOGIES INC |
Feb, 2020
|
ETHICON
|
EP2368914B1 | Anti-5T4 Antibodies And Uses Thereof | WYETH LLC |
Feb, 2020
|
SYNTHON BIOPHARMACEUTICALS
|
EP2393477B1 | Use Of A Glucocorticoid Composition For The Treatment Of Severe And Uncontrolled Asthma | VECTURA GMBH |
Feb, 2020
|
TEVA UK
|
EP2751267B1 | Methods For The Treatment Of Breast Cancer | SYNDAX PHARMACEUTICALS INC |
Feb, 2020
|
GENERICS UK
HEXAL
|
EP1731152B1 | Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine | EURO CELTIQUE SA |
Feb, 2020
|
GALLAFENT
HEXAL
TESA LABTEC
|
EP2665461B1 | Hair Coloring Compositions With A Non-Ammonia Alkalizing Agent | NOXELL CORP |
Feb, 2020
|
HENKEL
KAO GERMANY
|
EP3008064B1 | Stable Pemetrexed Arginine Salt And Compositions Comprising It | SYNTHON BV |
Feb, 2020
|
LARSEN & BIRKEHOLM
|
EP2611429B1 | Mesalazine Tablet Having Improved Dissolution | DISPHAR INTERNATIONAL BV |
Feb, 2020
|
TILLOTTS PHARMA
|
EP2211896B1 | Compositions For The Treatment Of Gastrointestinal Inflammation | MERITAGE PHARMA INC |
Jan, 2020
|
DR FALK PHARMA
PRFER & PARTNER MBB
|
EP2598119B1 | Preservative Free Brimonidine And Timolol Solutions | ALLERGAN INC |
Jan, 2020
|
INSTONE
WCHTERSHUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB
|
EP2694095B1 | Compositions Comprising Glucagon Analogs And Methods Of Making And Using The Same | LONGEVITY BIOTECH INC |
Jan, 2020
|
ZEALAND PHARMA
|
EP2789627B1 | Porcine Circovirus Type-2 Subunit Vaccine | SBC VIRBAC LTD |
Jan, 2020
|
MERIAL
|
EP3196301B1 | Methods And Compositions For The Treatment Of Monogenic Diseases | SANGAMO THERAPEUTICS INC |
Jan, 2020
|
LEEMING
MATHYS & SQUIRE
PATENT BOUTIQUE
|
EP2425824B1 | Pharmaceutical Preparation Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
Jan, 2020
|
ACINO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
GLENMARK PHARMACEUTICALS EUROPE
G L PHARMA
HEXAL SANDOZ
INTAS PHARMACEUTICALS
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
|
EP2961399B1 | Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters | JAZZ PHARMACEUTICALS IRELAND LTD |
Jan, 2020
|
HEXAL
HOFFMANN EITLE
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
|
EP2729165B1 | Immunogenic Combination Compositions And Uses Thereof | GLAXOSMITHKLINE BIOLOGICALS SA |
Jan, 2020
|
PFIZER
|
EP2512491B1 | Hbv Antisense Inhibitors | GLAXO GROUP LTD |
Jan, 2020
|
ROCHE INNOVATION CENTER COPENHAGEN
|
EP2900252B1 | Agent For Enhancing Immunity Containing Glutathione | KYOWA HAKKO BIO CO LTD |
Jan, 2020
|
HGF
|
EP2976059B1 | Agent For The Temporary Shaping Of Keratin-Containing Fibres | HENKEL AG AND CO KGAA |
Jan, 2020
|
LOREAL
|
EP2547217B1 | Infant Nutrition For Improving Fatty Acid Composition Of Brain Membranes | NUTRICIA NV |
Jan, 2020
|
NESTEC
|